Design and evaluation of 5'-modified nucleoside analogs as prodrugs for an E. coli purine nucleoside phosphorylase mutant.
about
Insights into Phosphate Cooperativity and Influence of Substrate Modifications on Binding and Catalysis of Hexameric Purine Nucleoside PhosphorylasesProgress and problems with the use of suicide genes for targeted cancer therapyEnzymes to die for: exploiting nucleotide metabolizing enzymes for cancer gene therapy.Structure-activity relationship for adenosine kinase from Mycobacterium tuberculosis II. Modifications to the ribofuranosyl moiety.Lactobacillus reuteri 2'-deoxyribosyltransferase, a novel biocatalyst for tailoring of nucleosides.Effect of expression of adenine phosphoribosyltransferase on the in vivo anti-tumor activity of prodrugs activated by E. coli purine nucleoside phosphorylase.
P2860
Design and evaluation of 5'-modified nucleoside analogs as prodrugs for an E. coli purine nucleoside phosphorylase mutant.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Design and evaluation of 5'-mo ...... cleoside phosphorylase mutant.
@en
type
label
Design and evaluation of 5'-mo ...... cleoside phosphorylase mutant.
@en
prefLabel
Design and evaluation of 5'-mo ...... cleoside phosphorylase mutant.
@en
P2093
P2860
P356
P1476
Design and evaluation of 5'-mo ...... cleoside phosphorylase mutant.
@en
P2093
A V Silamkoti
Abdalla E A Hassan
Anita T Fowler
Eric J Sorscher
John A Secrist
Paula W Allan
Steve E Ealick
William B Parker
William R Waud
P2860
P304
P356
10.1081/NCN-200059807
P577
2005-01-01T00:00:00Z